Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical

M Staudt1, J M Diederich1, C Meisel2

  • 1Department of Neurology, Charité University Medicine, Charitéplatz 1, 10117, Berlin, Germany.

BMC Neurology
|April 28, 2017
PubMed

Insights

Atypical chronic inflammatory demyelinating polyneuropathy (CIDP) shows distinct T cell differences compared to typical CIDP. These findings highlight potential immunological markers for diagnosing atypical CIDP variants.

Area of Science:

  • Immunology
  • Neurology
  • Cellular Biology

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) exhibits significant clinical heterogeneity.
  • Typical CIDP cases respond better to therapy than atypical variants.
  • Understanding immunological differences is crucial for differentiating CIDP subtypes.

Purpose of the Study:

  • To investigate cellular immunological distinctions between typical and atypical CIDP.
  • To compare immune responses in CIDP patients against healthy controls.

Main Methods:

  • Evaluated 26 CIDP patients (9 typical, 17 atypical) and 28 healthy controls.
  • Employed clinical and immunological assessments, including ELISPOT and FACS.
  • Utilized Kruskal-Wallis test for statistical comparisons.

Main Results:

  • Atypical CIDP patients displayed higher frequencies of CD4+ effector memory T cells (TEM) and CD4+ central memory T cells (TCM).
  • Elevated T cell responses against peripheral myelin antigens (PMP-22, P2, P0, MBP peptides) were observed in atypical CIDP.
  • Significantly increased T cell reactivity to P0 180-199 and MBP 82-100 peptides in atypical CIDP versus controls.

Conclusions:

  • Atypical CIDP is characterized by distinct T cell responses and an altered CD4+ memory compartment.
  • Peripheral myelin antigen-specific T cell responses are heightened in atypical CIDP.
  • Further multi-center studies are needed to validate these findings and develop diagnostic immunological markers.
Abstract